The translation factors of the artificial genome come from the bacterium Escherischia coli.
Credit: MPI f. Developmental Biology/ Jürgen Berger
Max Planck researchers have for the first time developed a genome the size of a minimal cell that can copy itself
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Synthetic biology
- BioP2P’s Matt Gardner to Speak at SynBioBeta Global Synthetic Biology Conference
Matt Gardner, Board President of the California Biomanufacturing Center and Chair of the BioProcess to Product Network (BioP2P), is scheduled to speak at the 2024 SynBioBeta Global Biology Conference.
- Ansa Biotechnologies to Showcase Early Access Customer Success at Upcoming Global Synthetic Biology Conference
Ansa Biotechnologies, Inc., the trusted partner for complex DNA synthesis, today announced its speaker lineup for presentations at the upcoming Global Synthetic Biology (SynBioBeta) Conference in San ...
- CRISPR-Crafted Cuisine: How Genetic Engineering Is Changing What We Eat
Hacking the genome of fungi for smart foods of the future. With animal-free dairy products and convincing vegetarian meat substitutes already on the market, it’s easy to see how biotechnology can ...
- Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the expansion of its LV Edge System with the launch of a fully stable cell line ...
- ARPA-H leaders to participate in Johns Hopkins Health Policy Forum discussion
School of Medicine Dean Theodore DeWeese will lead a conversation with Renee Wegrzyn, director of the Advanced Research Projects Agency for Health, and Kimberley Steele, ARPA-H program manager, on Apr ...
Go deeper with Google Headlines on:
Synthetic biology
[google_news title=”” keyword=”synthetic biology” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Artificial genome
- Scientists restore brain cells impaired by a rare genetic disorder
A therapy that restores brain cells impaired by a rare genetic disorder may offer a strategy for treating conditions like autism, epilepsy, and schizophrenia.
- AI-MARRVEL: A leap forward in diagnosing genetic diseases with over 98% precision
AIM is a machine-learning classifier that combines over 3.5 million variations from thousands of identified cases and expert-engineered variables to enhance molecular diagnosis. The team compared AIM ...
- CRISPR-Crafted Cuisine: How Genetic Engineering Is Changing What We Eat
Hacking the genome of fungi for smart foods of the future. With animal-free dairy products and convincing vegetarian meat substitutes already on the market, it’s easy to see how biotechnology can ...
- Genome Editing Genome Engineering Market Role of Artificial Intelligence in Survey Design Innovations and Trends
The latest research report from Report Ocean titled “Genome Editing Genome Engineering Market: Trends Analysis from 2024 to 2032”. This report delivers accurate economic projections, worldwide ...
- Artificial intelligence, machine learning boost animal science research
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
Go deeper with Google Headlines on:
Artificial genome
[google_news title=”” keyword=”artificial genome” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]